Targeting Glutamine Metabolism and PD-L1: A Novel Anti-tumor Pas de Deux

Autor: Naomi Taylor, Valerie Dardalhon, Maria I. Matias
Přispěvatelé: Institut de Génétique Moléculaire de Montpellier (IGMM), Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM), Hematopoïèse et Immunothérapie, Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM)
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Zdroj: Molecular Cell
Molecular Cell, Elsevier, 2020, 80 (4), pp.555-557. ⟨10.1016/j.molcel.2020.11.005⟩
ISSN: 1097-2765
DOI: 10.1016/j.molcel.2020.11.005⟩
Popis: Refers toJun-Kyu Byun, Mihyang Park, Seunghyeong Lee, Jae Won Yun, Jaebon Lee, Jae Sun Kim, Sung Jin Cho, Hui-Jeon Jeon, In-Kyu Lee, Yeon-Kyung Choi, Keun-Gyu ParkInhibition of Glutamine Utilization Synergizes with Immune Checkpoint Inhibitor to Promote Antitumor ImmunityMolecular Cell, Volume 80, Issue 4, 19 November 2020, Pages 592-606.e8; International audience; In this issue of Molecular Cell, Byun et al. (2020) find that the dual targeting of glutamine metabolism and the PD-L1 checkpoint inhibitor augments anti-tumor immunity. Mechanistically, decreased glutamine availability attenuated S-glutathionylation of SERCA, resulting in an increase in cytosolic calcium, enhanced NF-κB activity, and upregulation of programmed death-ligand 1.
Databáze: OpenAIRE